Literature DB >> 15726474

[Importance and factors related to chronic fatigue in multiple sclerosis].

R Alarcia1, J R Ara, J Martín, V Bertol, M Bestué.   

Abstract

INTRODUCTION: The importance of fatigue in multiple sclerosis (MS) is determined by its high frequency and it is an important cause of disability.
OBJECTIVE: To determine factors that are related to the presence of chronic fatigue in patients with MS. PATIENTS AND METHODS: The series comprises patients with MS, consecutively attended in the demyelinizating diseases unit, who met the following criteria: clinically definite MS (RR or SP), MS duration of more than two years, and no relapses during the previous month. Analyzed variables were as follows: chronic fatigue, demographic data, functional systems, EDSS, ISS, ESS, disease activity, Hamilton, depression scale GHQ-28, PSQI, and interferon. Statistical study: bivariate and multivariate analysis by logistic regression.
RESULTS: A hundred patients were included, 72 female and 28 male. Mean age was 39.27 years. Of the 100 patients 88 had RR disease and 12 SP disease. MS mean duration was 11.2 years. Mean EDSS 2.54. Chronic fatigue was 53 %. The presence of depression increased the probability of chronic fatigue 3.6 fold, and every point in PSQI-7 increases it 3.5 fold.
CONCLUSION: Depression and the PSQI-7 subscale (day sleep dysfunction) are the only variables independently related to chronic fatigue in patients with MS.

Entities:  

Mesh:

Year:  2005        PMID: 15726474

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  2 in total

1.  Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping.

Authors:  Chiara Zecca; Mauro Manconi; Davide Sparasci; Claudio Gobbi; Anna Castelnovo; Gianna Carla Riccitelli; Giulio Disanto
Journal:  J Neurol       Date:  2022-05-04       Impact factor: 6.682

2.  Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.

Authors:  Khadijeh Mohammadi; Parvin Rahnama; Ali Montazeri
Journal:  Ann Gen Psychiatry       Date:  2015-09-22       Impact factor: 3.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.